Clinical Trials on 肺灌注 in New Zealand
总计1040个结果
-
Middlemore Hospital, New Zealand未知
-
University of OtagoHealth Research Council, New Zealand完全的
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana Healthcare终止
-
GlaxoSmithKline完全的
-
Mundipharma Research Limited完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.终止
-
Biosplice Therapeutics, Inc.撤销
-
Teva Branded Pharmaceutical Products R&D, Inc.终止慢性阻塞性肺疾病美国, 澳大利亚, 新西兰
-
GlaxoSmithKline完全的
-
Novartis完全的
-
Monash Medical CentreMiddlemore Hospital, New Zealand; Prince of Wales Hospital, Sydney; Auckland City Hospital; Southern... 和其他合作者未知
-
Boehringer Ingelheim完全的
-
Pearl Therapeutics, Inc.完全的
-
GlaxoSmithKline完全的
-
McMaster UniversityHeart and Stroke Foundation of Ontario完全的
-
Aquinox Pharmaceuticals (Canada) Inc.完全的
-
Dey完全的